GW Pharmaceuticals, the biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its proprietary cannabinoid product platform, announced…
Browsing: Cannabinoids
Evidence mounts as a growing number of papers published in scientific journals are establishing that cannabinoids have anti-tumor effects on…
GW Pharmaceuticals plc (AIM: GWP), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid…
From 10th April, Sativex will become a Schedule 4 Part I drug and its continued availability for use in healthcare…
Naples, Italy: The administration of the nonpsychotropic cannabinoid cannabigerol (CBG) mitigates colitis (inflammation of the large intestine) in a preclinical…
Dr. David Allen discusses how the rules of engagement in the ‘war on drugs’ are being violated by the U.S.…
